The data underlying the results presented in the study are available from Parkinson's Progression Markers Initiative (PPMI)(<https://www.ppmi-info.org>).

Introduction {#sec005}
============

Parkinson's disease (PD) is characterized by motor symptoms, such as tremor, muscular rigidity, immobility and postural reflex disorder, and involves frequent complications of non-motor symptoms, such as autonomic nervous disorder, depression, sleep disturbance and dementia \[[@pone.0228289.ref001]\]. The incidence of PD has increased by more than double over the past 26 years, from 2.5 million patients in 1990 to 6.1 million patients in 2016 \[[@pone.0228289.ref002]\]. Pathologically, PD is characterized by the degeneration of the nigrostriatal dopamine nerve and the appearance of inclusion bodies containing α-synuclein as the main component, i.e. Lewy body \[[@pone.0228289.ref003],[@pone.0228289.ref004]\]. The striatum to which dopamine neurons are projected is one of the nerve nuclei constituting the basal ganglia and comprises the caudate nucleus and putamen. Dopamine transporter (DAT)-single photon emission computed tomography (SPECT) contributes to the diagnosis of PD and Lewy body dementia by providing a SPECT image reflecting DAT distribution density in the striatum. In general, the evaluation of DAT-SPECT images is visually performed using semi-quantitative indicators, such as specific binding ratio \[[@pone.0228289.ref005]--[@pone.0228289.ref008]\]. In visual assessment, information regarding the asymmetry of the left and right striata and accumulation site of ^123^I-FP-CIT can be obtained \[[@pone.0228289.ref009]--[@pone.0228289.ref012]\]. Conversely, semi-quantitative indicators can provide information regarding the count of the striatum in the background; however, the information of the striatum shape cannot be obtained. Few studies have used the shape of the striatum as a feature. Oliveira et al. \[[@pone.0228289.ref013]\] described that the length of the striatal uptake region revealed clinical added value because the accuracy obtained was slightly higher than the best accuracy achieved by the standard uptake ratio-based features. Staff et al.\[[@pone.0228289.ref014]\] indicated that the ratio of the long-to-short axis of the shape of the striatal uptake was as good as the putamen background ratio and experienced expert observers. Thus, the usefulness of using the shape feature in combination with the semi-quantitative indicator is evident. Further, it is well known that typical PD indicates egg or dot shape because a decrease in the uptake of the striatum occurs from the putamen and caudate uptake is retained. Kahraman et al. reported that 87 out of 120 cases of PD showed egg shape \[[@pone.0228289.ref009]\]. Therefore, we believed that it would be suitable to distinguish between PD and NC using the circularity of the striatal accumulation shape as a feature.

Machine learning is increasingly used in medical image identification and is also applied to the classification of DAT-SPECT image for the diagnosis of PD\[[@pone.0228289.ref015]--[@pone.0228289.ref019]\]. Generally, it is thought that the use of machine learning (ML) could improve the classification accuracy because discriminative features can be simultaneously used to build a more robust multidimensional classification model, as opposed to the models built based on a single feature. Also, in PD and NC classification using ML, the combination of semi-quantitative indicators and shape features could improve classification performance. The Development of an automatic DAT-SPECT diagnosis system that takes advantage of shape features can be divided into two parts. One is the extraction of the striatum. The other is the calculation and selection of effective shape features. We focused on calculation and selection of shape features.

This study aimed to indicate the usefulness of using circularity in shape features and assess the classification performance between PD and NC when semi-quantitative indicators and circularity are combined as a feature of ML.

Materials and methods {#sec006}
=====================

Parkinson's progression markers Initiative (PPMI) database {#sec007}
----------------------------------------------------------

The mission of PPMI is to identify one or more biomarkers of PD progression, a critical next step in the development of new and better treatment for PD. PPMI establishes comprehensive, standardized, longitudinal PD data and biological sample repository that is available to the research community \[[@pone.0228289.ref020]\]. All data used in this study were obtained from the PPMI database ([www.ppmi-info.org/data](http://www.ppmi-info.org/data)) available on April 3, 2018. The dataset contained all 625 pre-processed ^123^I-FP-CIT SPECT brain images acquired at the screening stage. A total of 100 cases of both PD and normal control (NC) were randomly selected. The PD group included 60 men and 40 women (65.7 ± 9.9 years, age range: 31--84 years), and the NC group included 57 men and 43 women (59.8 ± 11.5 years, age range: 39--89 years). SPECT images of the burst striatum type \[[@pone.0228289.ref009],[@pone.0228289.ref011],[@pone.0228289.ref021]\] were not included in selected groups. The burst striatum type is severe bilateral reduction with almost no uptake in either the putamen or caudate\[[@pone.0228289.ref007]\].

Informed consents were obtained for clinical testing and neuroimaging from the participants of the PPMI cohort. The study was approved by the institutional review boards of all participating institutions. We declare that all procedures in this study have been performed in accordance with the ethical standards laid down in the 1964 Declaration of Helsinki and its later amendments.

SPECT image processing and calculation of striatum binding ratio (SBR) by PPMI {#sec008}
------------------------------------------------------------------------------

Preprocessed SPECT images and SBRs were downloaded from the PPMI website. As by PPMI documentation, preprocessing steps were performed at the Institute for Neurodegenerative Disorders (IND, New Haven, CT) and included the following steps: SPECT imaging and reconstruction: SPECT imaging was acquired at each imaging centers as per the PPMI imaging protocol and sent to the institute for neurodegenerative disorders for processing and calculation of SBRs. SPECT raw projection data were imported to a HERMES (Hermes Medical Solutions, Stockholm, Sweden) system for iterative reconstruction. Iterative reconstruction was done without any filtering. The reconstructed files were transferred to the PMOD (PMOD Technologies, Zurich, Switzerland) for subsequent processing. Attenuation correction ellipses were drawn on the images and a Chang 0 attenuation correction was applied to images utilizing a site-specific μ that was empirically derived from phantom data acquired during site initiation for the trial. Once attenuation correction was completed, a standard Gaussian three-dimensional 6.0 mm filter was applied. Then, these files were normalized to standard Montreal Neurologic Institute space so that all scans were in the same anatomical alignment. The pre-processed images were saved as a DICOM format using 91 × 109 × 91 cubic voxels with 2 mm.

The calculation method of SBR as performed at the IND was as follows: the transaxial slice with the highest striatal uptake was identified, and the eight hottest striatal slices around it were averaged to generate a single slice image. Regions of interests (ROIs) were placed on the left and right striatal ROIs were covering and including all activity visualised in putamen and caudate (target region), and the occipital cortex (reference region). Count densities for each region were extracted and used to calculate the SBRs for each of the four striatal regions (left and right SBR~caudate~, left and right SBR~putamen~). SBRs were calculated as (target region/reference region)−1 \[[@pone.0228289.ref022]\].

Calculation of image feature {#sec009}
----------------------------

SPECT image features were calculated using MATLAB2018a (The MathWorks, Inc. Massachusetts, USA). We thought that the error and bias would increase if the contrast between the striatum and the background was low in a single SPECT image for ROI settings. Thus, multiple images were summed. Preliminary experiments showed that the maximum value above the parotid gland was in the left or right striatum. First, the maximum value and position of each slice above the parotid gland were searched. Next, a slice with the maximum value of the striatal part was searched. Then, a summed image was generated from the slice with maximum value and plus or minus two slices from the upper and lower slices (summed range: 1 cm). Region of interests were set to the left and right striata of the summed image by a radiological technologist who has experience in nuclear medicine field for 10 years. The region where the radioactivity is visually accumulated at the site where the striatum exists anatomically was manually delineated. The calculated shape features were as follows: area, equivalent diameter, major axis length, minor axis length, perimeter, and circularity. The circularity was calculated by following equation; $$circularity = \frac{4\pi S}{L^{2}},$$ here, S is the area of ROI, and L is the perimeter of ROI. Intensity features were maximum and minimum pixel count and the mean pixel count of the ROI.

Classification using machine learning {#sec010}
-------------------------------------

We used support vector machine (SVM) as a classifier for the classification of PD and NC. The SVM binary classification algorithm searches for an optimal hyperplane that separates the data into two classes, e.g., PD and NC. For separable classes, the optimal hyperplane maximizes a margin surrounding itself, which creates boundaries for the positive and negative classes. The features were standardized before learning. Leave-one-out cross validation (LOOV) method was performed to improve generalization performance. We compared classification performance when shape features or SBRs were used alone and in combination.

Statistical analysis {#sec011}
--------------------

The means of features in the PD and NC groups were tested for significant difference using Welch's t-test. The features were ranked by p-value. Furthermore, receiver operating characteristic (ROC) analysis was performed with the top five features and ML. We used the DeLong test to examine the difference in area under the curves (AUCs) between SBRs alone and shape features alone and SBRs with shape feature. The sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV) of each feature were calculated using the optimal cut-off values determined on the basis of ROC analysis. Differences with p-values \<0.05 were considered statistically significant.

Statistical calculations were carried out using JMP Pro 12 (SAS, Cary, NC, USA).

Results {#sec012}
=======

[Fig 1](#pone.0228289.g001){ref-type="fig"} shows typical examples of NC and PD summed SPECT images and image features. [Fig 2](#pone.0228289.g002){ref-type="fig"} shows the comparisons of shape and intensity features between the NC and PD groups. In shape features, area, equivocal diameter, major axis length, perimeter and circularity indicated significant differences ([Fig 2A--2E](#pone.0228289.g002){ref-type="fig"}, p \< 0.001). The circularity of the PD group was higher than that of the NC group. Minor axis length did not indicate significant difference ([Fig 2D](#pone.0228289.g002){ref-type="fig"}, p = 0.1091). In the intensity features, maximum and mean counts indicated significant differences ([Fig 2G and 2I](#pone.0228289.g002){ref-type="fig"}, p \< 0.001), and the minimum count did not indicate significant difference ([Fig 2H](#pone.0228289.g002){ref-type="fig"}, p = 0.5102).

![**Example of summed SPECT images and region of interests (ROIs) settings for normal control (left) and Parkinson's disease (right).** ROIs set on right (green line) and left (red line) striata, respectively. Shape features shows under each summed SPECT images.](pone.0228289.g001){#pone.0228289.g001}

![Comparisons of various features between normal control (NC) and Parkinson's disease (PD) groups.\
The features are area (a), equivocal diameter (b), major axis length (c), minor axis length (d), perimeter (e), circularity (f), maximum count (g), minimum count (h), and mean count (i).](pone.0228289.g002){#pone.0228289.g002}

[Fig 3](#pone.0228289.g003){ref-type="fig"} shows the comparisons of SBR~putamen~ and SBR~caudate~ between the NC and PD groups. Both SBR~putamen~ and SBR~caudate~ indicated significant differences (p \< 0.001). All features ranked in the ascending order of p-values are shown in [Table 1](#pone.0228289.t001){ref-type="table"}. The top five features were SBR~putamen,~ circularity, major axis length, SBR~caudate~ and perimeter. The ROC curves for the top five features are shown in [Fig 4](#pone.0228289.g004){ref-type="fig"}, and summarized in [Table 2](#pone.0228289.t002){ref-type="table"}. The AUC from the highest to the lowest were as follows: circularity (0.972), SBR~putamen~ (0.972), major axis length (0.945), SBR~caudate~ (0.928) and perimeter (0.896). Significant differences observed for both SBR~putamen~ vs SBR~caudate~ (p \< 0.0001), and SBR~putamen~ vs perimeter (p \< 0.0001).

![Comparisons of striatum binding ratios between normal control (NC) and Parkinson's disease (PD) groups.\
(a) SBR~putamen~, (b) SBR~caudate~.](pone.0228289.g003){#pone.0228289.g003}

![Receiver operating characteristic curves for the top five features.](pone.0228289.g004){#pone.0228289.g004}

10.1371/journal.pone.0228289.t001

###### Various image features ranked by p-values.

![](pone.0228289.t001){#pone.0228289.t001g}

  Ranking   Features             p values
  --------- -------------------- -----------
  1         SBR~putamen~         5.72E--88
  2         Circularity          2.80E--70
  3         Major axis length    1.72E--68
  4         SBR~caudate~         2.39E--63
  5         Perimeter            2.14E--44
  6         Area                 2.25E--27
  7         Equivocal diameter   7.64E--27
  8         Maximum count        2.58E--12
  9         Mean count           6.92E--08
  10        Minor axis length    1.09E--01
  11        Minimum count        5.10E--01

*SBR* striatum binding ratio

10.1371/journal.pone.0228289.t002

###### Area under the receiver operating characteristic curve of top five features.

![](pone.0228289.t002){#pone.0228289.t002g}

  --------------------------------------------------------------
  Features            AUC     95% CI         p value\
                                             (vs SBR~putamen~)
  ------------------- ------- -------------- -------------------
  SBR~putamen~        0.972   0.954--0.984   NA

  SBR~caudate~        0.928   0.900--0.950   \<0.0001

  Circularity         0.972   0.955--0.983   0.9842

  Major axis length   0.945   0.916--0.964   0.0394

  Perimeter           0.896   0.859--0.924   \<0.0001
  --------------------------------------------------------------

*SBR* striatum binding ratio, *AUC* area under the curve, *CI* confidence interval, *NA* not applicable

[Fig 5](#pone.0228289.g005){ref-type="fig"} shows ROC curves for ML with circularity or SBRs only and those with the combination. The highest AUC was obtained when the circularity and SBRs were combined (AUC = 0.995), followed by the circularity (AUC = 0.990), and then SBRs (AUC = 0.973). The classification performance was significantly improved by combining SBRs and circularity than by SBRs alone (p = 0.018) shown in [Table 3](#pone.0228289.t003){ref-type="table"}. No significant difference was observed between SBRs and circularity alone (p = 0.118) and between the combination and circularity alone (p = 0.208). The sensitivity and specificity are summarized in [Table 4](#pone.0228289.t004){ref-type="table"}. Classification accuracy was improved by combining SBRs and circularity than by SBRs alone.

![Receiver operating characteristic curves for the striatum binding ratios (SBRs) alone and circularity alone and in combination.](pone.0228289.g005){#pone.0228289.g005}

10.1371/journal.pone.0228289.t003

###### Area under the receiver operating characteristic curve of machine learning with several features.

![](pone.0228289.t003){#pone.0228289.t003g}

  ----------------------------------------------------------
  Features                AUC     95% CI         p value\
                                                 (vs SBRs)
  ----------------------- ------- -------------- -----------
  SBRs                    0.973   0.942--0.987   NA

  Circularity             0.990   0.977--0.996   0.118

  SBRs with Circularity   0.995   0.985--0.998   0.018
  ----------------------------------------------------------

*SBRs* striatum binding ratios, *AUC* area under the curve, *CI* confidence interval, *NA* not applicable

10.1371/journal.pone.0228289.t004

###### Classification accuracy of machine learning using SBRs and circularity as a feature.

![](pone.0228289.t004){#pone.0228289.t004g}

  Features                Sensitivity (%)   Specificity (%)
  ----------------------- ----------------- -----------------
  SBRs                    96.0              92.0
  Circularity             97.0              93.0
  SBRs with Circularity   98.0              95.0

*SBRs* striatum binding ratios

Discussion {#sec013}
==========

In this study, we evaluated the potential of shape features obtained from DAT-SPECT image to distinguish between the NC and PD groups. The shape features showed high performance equivocal to SBRs.

Obviously, the shape features indicated significant differences between the NC and PD groups, except the minor axis length. In normal cases, the DAT distribution is looks like a comma. On the contrary, in PD cases, DAT distribution has an egg shape. Therefore, the area, perimeter, equivocal diameter, circularity, and major axis lengths are affected by DAT distribution in the striatum. Oliveira et al. reported that the major axis length of the striatal region uptake is clinically useful and highly valuable to confirm dopaminergic degeneration as an aid to the diagnosis of Parkinson's disease \[[@pone.0228289.ref013]\]. However, minor axis length has not affected by comma and/or egg shape.

From the results of ROC analysis, we revealed that the performance of SBRs and shape features are equivalent. Circularity indicated the highest distinguishing performance among the shape features. The reason is that circularity is a mixed index of both area (rank 6th) and perimeter (rank 5th) which have moderate distinguishing performance. In comparison between SBRs, SBR~putamen~ showed high performance. ^123^I-FP-CIT decline begins from the putamen in PD, but accumulation is maintained in the caudate of both PD and NC. Therefore, SBR~putamen~ reflected accumulation difference of putamen and showed high performance. Intensity features showed low performance. When using the intensity of the striatum as an index, it should be used as a ratio to the background like SBR. In addition, semi-quantitative evaluation index such as SBR has various calculation methods, it is necessary to compare with these methods.

We compared the classification performance and accuracy of SVM when SBRs were used alone and when circularity was used in combination with SBRs to explore the effectiveness of the shape features in the classification of PD and NC. As a result, the classification performance and accuracy were improved. This result shows the effectiveness of adding a shape feature to SBRs. However, classification performance may be decreased depending on combined shape features. Therefore, the choice of effective shape features is important. We selected shape features for SVM on the basis of p-values by Welch's t-test. In the case of ML using many features, it is necessary to select a method that considered the interaction between the features.

Recently, a study reported the use of texture analysis \[[@pone.0228289.ref023],[@pone.0228289.ref024]\]. They reported a number of Haralick textural features in correlation with the clinical measures of UPDRS and disease duration. Further performance improvement could be expected using both shape and textural features together for classification. In future, it would be necessary to apply shape and textural features to ML. Based on the results of this study, shape features will be useful to distinguish between the NC and PD groups by ML. Furthermore, shape features with ML would be useful to distinguish regular PD from atypical PD and/or Parkinsonism.

This study has some limitations. In this study, we used SPECT images pre-processed by PPMI. These images were reconstructed by a specific reconstruction method and normalized as preprocessing. However, differences in the image reconstruction method and normalization may affect the setting of ROI, and ultimately affect the calculation of the image features. In particular, when the count of the striatum is very low, it is assumed that these influences are large, and there is a possibility that the decreasing classification performance. ROIs for obtaining the shape features were set to the striatum by manual tracing. Thus, the shape features were affected by individual observational differences. To reduce the individual differences, an automatic ROI setting method should be developed. We used only 100 cases of both PD and NC. Therefore, to improve the robustness of the proposed method, future investigations should consider increasing the number of cases.

In conclusion, we found that the shape feature, namely circularity obtained from DAT-SPECT images, could help in distinguishing between NC and PD comparable to SBRs. Furthermore, the classification performance of ML was significantly improved using circularity as a semi-quantitative indicator together. Therefore, circularity can be a useful quantitative index in the diagnostic process of PD and NC.

Data used in this study were obtained from the PPMI database ([www.ppmi-info.org/data](http://www.ppmi-info.org/data)). PPMI, a public--private partnership, is funded by the Michael J. Fox Foundation for Parkinson's Research and funding partners, including Abbvie, Avid, Biogen, Bristol-Myers Squib, Covance, GE Healthcare, Genentech, GlaxoSmithKline, Eli Lilly & Co, Lundbeck, Merck, Meso Scale Discovery, Pfizer, Piramal, Roche, Servier and UCB.

10.1371/journal.pone.0228289.r001

Decision Letter 0

Kassubek

Jan

Academic Editor

© 2020 Jan Kassubek

2020

Jan Kassubek

This is an open access article distributed under the terms of the

Creative Commons Attribution License

, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

3 Oct 2019

PONE-D-19-23329

Improvement of classification performance of Parkinson's disease using shape features for machine learning on dopamine transporter single photon emission computed tomography

PLOS ONE

Dear Dr Shiiba,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE's publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

We would appreciate receiving your revised manuscript by Nov 17 2019 11:59PM. When you are ready to submit your revision, log on to <https://www.editorialmanager.com/pone/> and select the \'Submissions Needing Revision\' folder to locate your manuscript file.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter.

To enhance the reproducibility of your results, we recommend that if applicable you deposit your laboratory protocols in protocols.io, where a protocol can be assigned its own identifier (DOI) such that it can be cited independently in the future. For instructions see: <http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols>

Please include the following items when submitting your revised manuscript:

A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). This letter should be uploaded as separate file and labeled \'Response to Reviewers\'.A marked-up copy of your manuscript that highlights changes made to the original version. This file should be uploaded as separate file and labeled \'Revised Manuscript with Track Changes\'.An unmarked version of your revised paper without tracked changes. This file should be uploaded as separate file and labeled \'Manuscript\'.

Please note while forming your response, if your article is accepted, you may have the opportunity to make the peer review history publicly available. The record will include editor decision letters (with reviews) and your responses to reviewer comments. If eligible, we will contact you to opt in or out.

We look forward to receiving your revised manuscript.

Kind regards,

Jan Kassubek

Academic Editor

PLOS ONE

Journal Requirements:

When submitting your revision, we need you to address these additional requirements.

1\. Please ensure that your manuscript meets PLOS ONE\'s style requirements, including those for file naming. The PLOS ONE style templates can be found at <http://www.journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf> and <http://www.journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf>

Additional Editor Comments (if provided):

Although both reviewers saw strengths in your manuscript, both also noted major limitations which should be addressed in a revised version.

\[Note: HTML markup is below. Please do not edit.\]

Reviewers\' comments:

Reviewer\'s Responses to Questions

**Comments to the Author**

1\. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer \#1: Partly

Reviewer \#2: Partly

\*\*\*\*\*\*\*\*\*\*

2\. Has the statistical analysis been performed appropriately and rigorously?

Reviewer \#1: No

Reviewer \#2: Yes

\*\*\*\*\*\*\*\*\*\*

3\. Have the authors made all data underlying the findings in their manuscript fully available?

The [PLOS Data policy](http://www.plosone.org/static/policies.action#sharing) requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data---e.g. participant privacy or use of data from a third party---those must be specified.

Reviewer \#1: Yes

Reviewer \#2: No

\*\*\*\*\*\*\*\*\*\*

4\. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer \#1: Yes

Reviewer \#2: Yes

\*\*\*\*\*\*\*\*\*\*

5\. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer \#1: This is an interesting study applying a novel and promising method.

I have only one (yet major) issue:

It is unclear to me, how the boundaries for the shape of the striatum were set. It reads like it was done visually, which is suboptimal, given that the aim of the method is automated quantification, or diagnosis.

There are several other minor issues:

1\. Please state in the methods that you downloaded the reconstructed imaging data. The preprocessing steps were performed our of your hands and should be referenced (e.g. in a prior publication, or website reference)

2\. How did you determine, what a \"burst striatum\" constitutes, when you excluded this data?

3\. How did you search for the maximum value of the striatal part to determine the medium of the 5 slices that you averaged?

4\. line 243 (page 16) : typo \"distribution \*is\* looks like\"

5\. either use sensitivity/specificity or true positive/negative rate as terminology, not both, which can be confusing

6\. To state PPV and NPV in a preselected sample is not meaningful and can be misleading (see consensus statement in <https://doi.org/10.1016/j.dadm.2019.01.011>, PMID 30984816)

Reviewer \#2: Materials and methods

Line 120: please specify which method for image normalization was used and how correct normalization was checked for. In datasets with little striatal activity all normalization methods not using coregistered morphological images for determination of normalization parameters are error-prone and may lead to considerable distortion of images, particularly when the primary reconstructed dataset has unusual starting coordinates as often is the case in parkinsonian patients with stiff neck musculature. As shape feature extraction is particularly prone to bias from distortion due to normalization procedure, requirements on robustness of normalization are high and would need some kind of assessment. One could think of submitting the same dataset to normalization with a couple of differently angulated starting coefficients and measuring reproducibility of shape measures for different extremes, especially for cases where there is little putaminal activity left.

Calculation of image features:

Line 130ff: Are the authors suggesting that for image feature extraction no differentiation between caudate and putaminal activity was done? If so, this would have to be stated explicitly and its implication for disease subentities with predominant caudate pathology discussed. Also, the procedure to determine the „slice with highest striatal activity" has to be described, as the results will be different if highest activity is measured for caudate, putaminal or global regional activity, and dorsal putaminal slices might not be contributing to summed images if highest activity is in apicoventral caudate. Also, slice thickness of reconstructed images is not reported, but has considerable impact on summed images. Please specify.

Line 133: „regions of interest were set\...". What were the criteria for delineation of striatum? Did the technologist delineate based on morphological images or did he just „paint a contour where activity was"? Were there standardized criteria for contouring besides „ten years of experience?" - As contouring may have considerable effect on shape feature extraction, as the authors correctly note in the discussion section, it has to be explained how bias by contouring was addressed, especially in „low-count-images", and Assessment of error propagation should be done for reconstruction-attenuation correction-normalization-contouring-feature extraction.

Results:

Figures show only results of statistical tests. Without image examples, the reader cannot assess the impact of shape feature extraction on tests. Typical images and according shape features should be presented additionally.

Discussion:

The authors should discuss the effect of their specific reconstruction method on the results as compared to standard clinical reconstructed images. On this behalf, it is suggested to repeat their classification methods with reconstructed datasets as present in the database and compare with their standardized reconstructed datasets in order to assess robustness of classification under standard clinical conditions.

\*\*\*\*\*\*\*\*\*\*

6\. PLOS authors have the option to publish the peer review history of their article ([what does this mean?](https://journals.plos.org/plosone/s/editorial-and-peer-review-process#loc-peer-review-history)). If published, this will include your full peer review and any attached files.

If you choose "no", your identity will remain anonymous but your review may still be made public.

**Do you want your identity to be public for this peer review?** For information about this choice, including consent withdrawal, please see our [Privacy Policy](https://www.plos.org/privacy-policy).

Reviewer \#1: No

Reviewer \#2: No

\[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link \"View Attachments\". If this link does not appear, there are no attachment files to be viewed.\]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, <https://pacev2.apexcovantage.com/>. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email us at <figures@plos.org>. Please note that Supporting Information files do not need this step.

10.1371/journal.pone.0228289.r002

Author response to Decision Letter 0

18 Nov 2019

We are grateful to reviewers for the critical comments and useful suggestions that have helped us to improve our manuscript considerably. As indicated in the responses that follow, we have taken all these comments and suggestions into account in the revised version of our manuscript.

Reviewer \#1: This is an interesting study applying a novel and promising method.

I have only one (yet major) issue:

It is unclear to me, how the boundaries for the shape of the striatum were set. It reads like it was done visually, which is suboptimal, given that the aim of the method is automated quantification, or diagnosis.

Response

We strongly appreciate the reviewer \#1's comment. A radiological technologist with 10 years of experience in nuclear medicine visually set the boundaries of the striatum. In accordance with reviewer's comment, we have added the text in the Materials and Methods (Page 10 , Line 146--147):

"The region where the radioactivity is visually accumulated at the site where the striatum exists anatomically was surrounded."

We believe that the development of an automatic diagnosis system that takes advantage of shape features can be divided into two parts. One is the extraction of the striatum. The other is the calculation and selection of effective shape features. The purpose of this study is the latter. Therefore, in accordance with reviewer's comment, we have added the text in the Introduction as follows (Page 6, Line 85--88):

"The Development of an automatic DAT-SPECT diagnosis system that takes advantage of shape features can be divided into two parts. One is the extraction of the striatum. The other is the calculation and selection of effective shape features. We focused on calculation and selection of shape features."

There are several other minor issues:

1\. Please state in the methods that you downloaded the reconstructed imaging data. The preprocessing steps were performed our of your hands and should be referenced (e.g. in a prior publication, or website reference)

Response

In accordance with reviewer's comment, we have added the text in the Materials and Methods as follows (Page 6, Line 96--99):

"All data used in this study were obtained from the PPMI database (www.ppmi- [info.org/data](http://info.org/data)) available on April 3, 2018. The dataset contained all 625 pre-processed 123I-FP-CIT SPECT brain images acquired at the screening stage."

2\. How did you determine, what a \"burst striatum\" constitutes, when you excluded this data?

Response

It was an expression error. It was not "excluded", but correctly \"was not included\". In accordance with reviewer's comment, we have revised the text in the Materials and Methods from:

"SPECT images of the burst striatum type \[9,11,21\] were excluded."

to

"SPECT images of the burst striatum type \[9,11,21\] were not included in selected groups." (Page 7, Line 101--102)

3\. How did you search for the maximum value of the striatal part to determine the medium of the 5 slices that you averaged?

Response

As a preliminary experiment, we searched for the maximum value in all slices above the parotid gland. As a result, we found that the maximum value almost exists in either the left or right striatum. In accordance with reviewer's comment, we have revised the text in the Materials and Methods as follows (Page 9, Line137--142):

"Preliminary experiments showed that the maximum pixel value above the parotid gland was in the left or right striatum. First, the highest pixel value and position of each slice above the parotid gland were searched. Next, a slice with the maximum value of the striatal part was searched."

4\. line 243 (page 16) : typo \"distribution \*is\* looks like\"

Response

Thank you for your careful peer review. Our manuscript has been checked natively, how should it be corrected?

5\. either use sensitivity/specificity or true positive/negative rate as terminology, not both, which can be confusing

Response

In accordance with reviewer's comment, in the revised version, we unified the terms (sensitivity and specificity). Vertical and horizontal axes have changed in Figures 3 and 4.

6\. To state PPV and NPV in a preselected sample is not meaningful and can be misleading (see consensus statement in <https://doi.org/10.1016/j.dadm.2019.01.011>, PMID 30984816)

Response

In accordance with reviewer's comment, we decided to not use PPV and NPV. We have removed PPV and NPV in Table 4, and have revised the text in the Results from:

"The sensitivity, specificity, PPV, and NPV are summarized in Table 4."

to

"The sensitivity and specificity are summarized in Table 4." (Page 15, Line 227--228)

We wish to thank the reviewer again for his or her valuable comments.

Reviewer \#2: Materials and methods

Line 120: please specify which method for image normalization was used and how correct normalization was checked for. In datasets with little striatal activity all normalization methods not using coregistered morphological images for determination of normalization parameters are error-prone and may lead to considerable distortion of images, particularly when the primary reconstructed dataset has unusual starting coordinates as often is the case in parkinsonian patients with stiff neck musculature. As shape feature extraction is particularly prone to bias from distortion due to normalization procedure, requirements on robustness of normalization are high and would need some kind of assessment. One could think of submitting the same dataset to normalization with a couple of differently angulated starting coefficients and measuring reproducibility of shape measures for different extremes, especially for cases where there is little putaminal activity left.

Response

We strongly appreciate the reviewer 's comment. PPMI does not disclose details about image normalization. To our knowledge, it was not mentioned in other papers. Therefore, we added following the text to discussion (P19, L283--289).

"In this study, we used SPECT images pre-processed by PPMI. These images were reconstructed by a specific reconstruction method and normalized as pre-processing. However, differences in the image reconstruction method and normalization may affect the setting of ROI, and ultimately affect the calculation of the image features. In particular, when the count of the striatum is very low, it is assumed that these influences are large, and there is a possibility that the decreasing classification performance."

Calculation of image features:

Line 130ff: Are the authors suggesting that for image feature extraction no differentiation between caudate and putaminal activity was done? If so, this would have to be stated explicitly and its implication for disease subentities with predominant caudate pathology discussed. Also, the procedure to determine the „slice with highest striatal activity" has to be described, as the results will be different if highest activity is measured for caudate, putaminal or global regional activity, and dorsal putaminal slices might not be contributing to summed images if highest activity is in apicoventral caudate. Also, slice thickness of reconstructed images is not reported, but has considerable impact on summed images. Please specify.

Response

We searched for the highest pixel value in each slice above the parotid gland and selected the slice with the highest pixel value. As a result, we confirmed that the highest pixel value exists in either the left or right striatum in this database. An image was created by adding the upper and lower slices to the slice. We have added description about image matrix size (Page 9, Line 126--127).

"The pre-processed images were saved as a DICOM format using 91 × 109 × 91 cubic voxels with 2 mm. "

In accordance with reviewer's comment, we have revised the text in the Materials and Methods as follows (Page 9, Line 1379--144):

"Preliminary experiments showed that the maximum pixel value above the parotid gland was in the left or right striatum. First, the highest pixel value and position of each slice above the parotid gland were searched. Next, a slice with the maximum value of the striatal part was searched. Then, a summed image was generated from the slice with maximum value and plus or minus two slices from the upper and lower slices (summed range: 1 cm)."

Line 133: „regions of interest were set\...". What were the criteria for delineation of striatum? Did the technologist delineate based on morphological images or did he just „paint a contour where activity was"? Were there standardized criteria for contouring besides „ten years of experience?" - As contouring may have considerable effect on shape feature extraction, as the authors correctly note in the discussion section, it has to be explained how bias by contouring was addressed, especially in „low-count-images", and Assessment of error propagation should be done for reconstruction-attenuation correction-normalization-contouring-feature extraction.

Response

Based on anatomical knowledge, a radiological technologist has set a region of interest in where radioactivity exists visually in the striatum. The summation image is used instead of one slice so that the region of interest setting of the striatum is less biased.

We added following the text to Materials and Methods as following (Page 9, Line 137--139):

"We thought that the error and bias would increase if the contrast between the striatum and the background was low in a single SPECT image for ROI settings."

Also, we added following the text to discussion as following (P19, L283--289):

"In this study, we used SPECT images pre-processed by PPMI. These images were reconstructed by a specific reconstruction method and normalized as preprocessing. However, differences in the image reconstruction method and normalization may affect the setting of ROI, and ultimately affect the calculation of the image features. In particular, when the count of the striatum is very low, it is assumed that these influences are large, and there is a possibility that the decreasing classification performance."

Results:

Figures show only results of statistical tests. Without image examples, the reader cannot assess the impact of shape feature extraction on tests. Typical images and according shape features should be presented additionally.

Response

A typical example of NC and PD images and image features was added as Figure 1. Along with above, we added text to Results as follows:

"Figure 1 shows typical examples of NC and PD summed SPECT images and image features."

"Fig 1 Example of summed SPECT images and region of interests (ROIs) settings for normal control (left) and Parkinson's disease (right). ROIs set on right (green line) and left (red line) striata, respectively. Shape features shows under each summed SPECT images."

Discussion:

The authors should discuss the effect of their specific reconstruction method on the results as compared to standard clinical reconstructed images. On this behalf, it is suggested to repeat their classification methods with reconstructed datasets as present in the database and compare with their standardized reconstructed datasets in order to assess robustness of classification under standard clinical conditions.

Response

Thank you for your helpful comments. Since we do not have a standard reconstruction processing device, we added the Discussion as follows (P19, L283--289):

"In this study, we used SPECT images pre-processed by PPMI. These images were reconstructed by a specific reconstruction method and normalized as preprocessing. However, differences in the image reconstruction method and normalization may affect the setting of ROI, and ultimately affect the calculation of the image features. In particular, when the count of the striatum is very low, it is assumed that these influences are large, and there is a possibility that the decreasing classification performance."

We wish to thank the Reviewer again for his or her valuable comments.
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Submitted filename: Respose to Reviewers.docx
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Click here for additional data file.
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Improvement of classification performance of Parkinson's disease using shape features for machine learning on dopamine transporter single photon emission computed tomography

PLOS ONE

Dear Dr Shiiba,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE's publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

We would appreciate receiving your revised manuscript by Feb 14 2020 11:59PM. When you are ready to submit your revision, log on to <https://www.editorialmanager.com/pone/> and select the \'Submissions Needing Revision\' folder to locate your manuscript file.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter.

To enhance the reproducibility of your results, we recommend that if applicable you deposit your laboratory protocols in protocols.io, where a protocol can be assigned its own identifier (DOI) such that it can be cited independently in the future. For instructions see: <http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols>

Please include the following items when submitting your revised manuscript:

A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). This letter should be uploaded as separate file and labeled \'Response to Reviewers\'.A marked-up copy of your manuscript that highlights changes made to the original version. This file should be uploaded as separate file and labeled \'Revised Manuscript with Track Changes\'.An unmarked version of your revised paper without tracked changes. This file should be uploaded as separate file and labeled \'Manuscript\'.

Please note while forming your response, if your article is accepted, you may have the opportunity to make the peer review history publicly available. The record will include editor decision letters (with reviews) and your responses to reviewer comments. If eligible, we will contact you to opt in or out.

We look forward to receiving your revised manuscript.

Kind regards,

Jan Kassubek

Academic Editor

PLOS ONE

Additional Editor Comments (if provided):

The reviewers appreciated the detailed revision of the manuscript. However, Reviewer 2 still raises some remaining concerns which might be addressed in a (minor) revision of the manuscript.

\[Note: HTML markup is below. Please do not edit.\]

Reviewers\' comments:

Reviewer\'s Responses to Questions

**Comments to the Author**

1\. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the "Comments to the Author" section, enter your conflict of interest statement in the "Confidential to Editor" section, and submit your \"Accept\" recommendation.

Reviewer \#1: All comments have been addressed

Reviewer \#2: (No Response)

\*\*\*\*\*\*\*\*\*\*

2\. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer \#1: Yes

Reviewer \#2: Partly

\*\*\*\*\*\*\*\*\*\*

3\. Has the statistical analysis been performed appropriately and rigorously?

Reviewer \#1: Yes

Reviewer \#2: Yes

\*\*\*\*\*\*\*\*\*\*

4\. Have the authors made all data underlying the findings in their manuscript fully available?

The [PLOS Data policy](http://www.plosone.org/static/policies.action#sharing) requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data---e.g. participant privacy or use of data from a third party---those must be specified.

Reviewer \#1: Yes

Reviewer \#2: No

\*\*\*\*\*\*\*\*\*\*

5\. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer \#1: Yes

Reviewer \#2: Yes

\*\*\*\*\*\*\*\*\*\*

6\. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer \#1: (No Response)

Reviewer \#2: The comments raised are partially addressed. While the revised manuscript now comments on preprocessing by PPMI, the methods section still comments confusingly on processing of SPECT raw data, which is not intelligible by an average reader not accustomed to the PPMI database. In fact, the reviewer had to gain access to the PPMI database and check himself on the data to fully understand what the authors were doing. Please consider the following points:

line 130ff: the authors still do not specify if striatal activity was differentiating caudate activity from putaminal activity. It seems they just differentiated left striatal activity from right striatal activity. They might insert a line \"left and right striatal ROIs were covering and including all activity visualised in putamen and caudate\"

Line 113 typo PPIM instead of PPMI

Line 114: \"SPECT images and SBRs were downloaded from the PPMI website\" - please change to \"Preprocessed SPECT images and SBRs were downloaded from the PPMI website\".

Line 114 ff: \"SPECT imaging was acquired at each imaging centers as per the PPMI imaging protocol\...\" The current wording suggests that this part of processing had been done by the authors. In fact the whole paragraph following is plagiating the PPMI methods section where the preprocessing steps performed by PPMI are described, which is misleading the reader. Please consider the following wording:

\"As by PPMI documentation, preprocessing steps were performed at the Institute for Neurodegenerative Disorders (IND, New Haven, CT) and included the following steps: SPECT imaging and reconstruction: SPECT imaging \"was acquired at each imaging centers as per the PPMI imaging protocol \[\..., up to line 127\]. (line 128 insert:) The calculation method of SBR as performed at the IND was as follows: the transaxial slice with\...

line 146: \" The region where the radioactivity is

visually accumulated at the site where the striatum exists anatomically was surrounded\" - please replace \"surrounded\" by \"manually delineated\"

Additional comment: reviewer 1 asked for definition of \"burst striatum\" which is not given in the revised document. Please provide.

\*\*\*\*\*\*\*\*\*\*

7\. PLOS authors have the option to publish the peer review history of their article ([what does this mean?](https://journals.plos.org/plosone/s/editorial-and-peer-review-process#loc-peer-review-history)). If published, this will include your full peer review and any attached files.

If you choose "no", your identity will remain anonymous but your review may still be made public.

**Do you want your identity to be public for this peer review?** For information about this choice, including consent withdrawal, please see our [Privacy Policy](https://www.plos.org/privacy-policy).

Reviewer \#1: Yes: Thilo van Eimeren

Reviewer \#2: No

\[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link \"View Attachments\". If this link does not appear, there are no attachment files to be viewed.\]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, <https://pacev2.apexcovantage.com/>. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email us at <figures@plos.org>. Please note that Supporting Information files do not need this step.

10.1371/journal.pone.0228289.r004

Author response to Decision Letter 1

7 Jan 2020

We are grateful to reviewers for the critical comments and useful suggestions that have helped us to improve our manuscript considerably. As indicated in the responses that follow, we have taken all these comments and suggestions into account in the revised version of our manuscript.

line 130ff: the authors still do not specify if striatal activity was differentiating caudate activity from putaminal activity. It seems they just differentiated left striatal activity from right striatal activity. They might insert a line \"left and right striatal ROIs were covering and including all activity visualised in putamen and caudate\"

Response

We strongly appreciate the reviewer's comment. In accordance with reviewer's comment, we have changed the text in the Materials and Methods (P10L134) as from:

"Regions of interests (ROIs) were placed on the left and right caudate and putamen (target region) and the occipital cortex (reference region)."

to

"Regions of interests (ROIs) were placed on the left and right (target region) and the occipital cortex (reference region)."

Line 113 typo PPIM instead of PPMI

Response

We strongly appreciate the reviewer's comment. In accordance with reviewer's comment, we have revised from "PPIM" to "PPMI"(P8L114).

Line 114: \"SPECT images and SBRs were downloaded from the PPMI website\" - please change to \"Preprocessed SPECT images and SBRs were downloaded from the PPMI website\".

Response

We strongly appreciate the reviewer's comment. In accordance with reviewer's comment, we have changed the text in the Materials and Methods (P8L115) as from:

"SPECT images and SBRs were downloaded from the PPMI website."

to

"Preprocessed SPECT images and SBRswere downloaded from the PPMI website."

Line 114 ff: \"SPECT imaging was acquired at each imaging centers as per the PPMI imaging protocol\...\" The current wording suggests that this part of processing had been done by the authors. In fact the whole paragraph following is plagiating the PPMI methods section where the preprocessing steps performed by PPMI are described, which is misleading the reader. Please consider the following wording:

\"As by PPMI documentation, preprocessing steps were performed at the Institute for Neurodegenerative Disorders (IND, New Haven, CT) and included the following steps: SPECT imaging and reconstruction: SPECT imaging \"was acquired at each imaging centers as per the PPMI imaging protocol \[\..., up to line 127\]. (line 128 insert:) The calculation method of SBR as performed at the IND was as follows: the transaxial slice with\...

Response

We strongly appreciate the reviewer's comment. In accordance with reviewer's comment, we have added the text in the Materials and Methods (P8L116) as follows:

As by PPMI documentation, preprocessing steps were performed at the Institute for Neurodegenerative Disorders (IND, New Haven, CT) and included the following steps: SPECT imaging and reconstruction:

Also, we have changed the text (P9L132) as following:

The calculation method of SBR as performed at the IND was as follows: the transaxial slice with the highest striatal uptake was identified, and the eight hottest striatal slices around it were averaged to generate a single slice image.

line 146: \" The region where the radioactivity is visually accumulated at the site where the striatum exists anatomically was surrounded\" - please replace \"surrounded\" by \"manually delineated\"

Response

We strongly appreciate the reviewer's comment. In accordance with reviewer's comment, we have changed the text in the Materials and Methods (P10L152) as from:

"The region where the radioactivity is visually accumulated at the site where the striatum exists anatomically was surrounded."

to

"The region where the radioactivity is visually accumulated at the site where the striatum exists anatomically was manually delineated."

Additional comment: reviewer 1 asked for definition of \"burst striatum\" which is not given in the revised document.4 Please provide.

Response

We strongly appreciate the reviewer's comment. In accordance with reviewer's comment, we have added the text in the Materials and Methods (P7L105) as following:

The burst striatum type is severe bilateral reduction with almost no uptake in either the putamen or caudate\[7\].

We wish to thank the Reviewer again for his or her valuable comments.
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PONE-D-19-23329R2

Dear Dr. Shiiba,

We are pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it complies with all outstanding technical requirements.

Within one week, you will receive an e-mail containing information on the amendments required prior to publication. When all required modifications have been addressed, you will receive a formal acceptance letter and your manuscript will proceed to our production department and be scheduled for publication.

Shortly after the formal acceptance letter is sent, an invoice for payment will follow. To ensure an efficient production and billing process, please log into Editorial Manager at <https://www.editorialmanager.com/pone/>, click the \"Update My Information\" link at the top of the page, and update your user information. If you have any billing related questions, please contact our Author Billing department directly at <authorbilling@plos.org>.

If your institution or institutions have a press office, please notify them about your upcoming paper to enable them to help maximize its impact. If they will be preparing press materials for this manuscript, you must inform our press team as soon as possible and no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact <onepress@plos.org>.

With kind regards,

Jan Kassubek

Academic Editor

PLOS ONE

Additional Editor Comments (optional):

All reviewers´comments have been appropriately addressed.

Reviewers\' comments:

Reviewer\'s Responses to Questions

**Comments to the Author**

1\. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the "Comments to the Author" section, enter your conflict of interest statement in the "Confidential to Editor" section, and submit your \"Accept\" recommendation.

Reviewer \#2: All comments have been addressed

\*\*\*\*\*\*\*\*\*\*

2\. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer \#2: Yes

\*\*\*\*\*\*\*\*\*\*

3\. Has the statistical analysis been performed appropriately and rigorously?

Reviewer \#2: Yes

\*\*\*\*\*\*\*\*\*\*

4\. Have the authors made all data underlying the findings in their manuscript fully available?

The [PLOS Data policy](http://www.plosone.org/static/policies.action#sharing) requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data---e.g. participant privacy or use of data from a third party---those must be specified.

Reviewer \#2: Yes

\*\*\*\*\*\*\*\*\*\*

5\. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer \#2: Yes

\*\*\*\*\*\*\*\*\*\*

6\. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer \#2: The authors have addressed all comments appropriately. There is only one mishap in the revised manuscript, where at page 9, Line 13 comments and original text have been mixed and the manuscript now reads \"Regions of interests (ROIs) were placed on the left and right striatal ROIs were covering and including all activity visualised in putamen and caudate (target region), and the occipital cortex (reference region).\", while it should read \"Regions of interests (ROIs) were covering and including all activity visualised in putamen and caudate (target region), and the occipital cortex (reference region).\"

\*\*\*\*\*\*\*\*\*\*

7\. PLOS authors have the option to publish the peer review history of their article ([what does this mean?](https://journals.plos.org/plosone/s/editorial-and-peer-review-process#loc-peer-review-history)). If published, this will include your full peer review and any attached files.

If you choose "no", your identity will remain anonymous but your review may still be made public.

**Do you want your identity to be public for this peer review?** For information about this choice, including consent withdrawal, please see our [Privacy Policy](https://www.plos.org/privacy-policy).

Reviewer \#2: Yes: Freimut D. Juengling

10.1371/journal.pone.0228289.r006
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Dear Dr. Shiiba:

I am pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department.

If your institution or institutions have a press office, please notify them about your upcoming paper at this point, to enable them to help maximize its impact. If they will be preparing press materials for this manuscript, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact <onepress@plos.org>.

For any other questions or concerns, please email <plosone@plos.org>.

Thank you for submitting your work to PLOS ONE.

With kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Prof. Dr. Jan Kassubek

Academic Editor

PLOS ONE
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